Supplementary Table S1.

Inclusion and Exclusion Criteria

Inclusion criteria

1. All inpatient referrals to Dermatology service between 1 January 2017 and 30 June 2020 in whom a cutaneous fungal infection was suspected on initial review by the dermatologist.

2. Cutaneous fungal infections included in our study are:

a. Superficial dermatophyte infections such as tinea

b. Superficial yeast infections such as pityrosporum folliculitis

c. Intertrigo for which cutaneous fungal infection was suspected and evaluated for

d. Deep cutaneous fungal infections or disseminated cutaneous fungal infections such as disseminated candidiasis

3. KOH smear was recommended by the dermatologist to evaluate the suspected cutaneous fungal infection and was performed.

4. The result of the KOH smear was reviewed by the dermatologist within the same admission.

5. Management plans were given after the KOH smear result was reviewed.

Exclusion criteria

1. Patients who were receiving systemic antifungals for reasons other than suspected cutaneous fungal infection, such as for prophylaxis in an immunocompromised patient

2. Mucosal fungal infections

3. Onychomycosis

4. Patients whose KOH smear results were not reviewed by the dermatologist within the same admission and thus did not receive timely management plans from the dermatologist